体外膜氧合支持儿童的量化出血与结局
该研究为大型观察性队列研究的二次分析,纳入8家儿科机构中514例连续接受体外膜氧合支持的危重患儿,前瞻性收集每日胸管出血量、止血检测结果、输血量、90天无PICU天数及死亡率。60%患儿至少发生一次胸管出血,整个体外膜氧合疗程胸管出血量中位数为123 mL/kg(四分位距47-319 mL/kg),26%患儿至少1天胸管出血>100 mL/kg/d。胸管出血>60 mL/kg/d的天数与住院死亡率升高(调整OR 1.43,95%CI 1.05-1.97,p=0.02)及无PICU天数减少(β=-4.2,95%CI -7.7至-0.6,p=0.02)独立相关;胸管出血总量与死亡率升高独立相关(每mL/kg/体外膜氧合疗程,调整OR 1.002,95%CI 1.000-1.003,p=0.04)。纤维蛋白原、体重、体外膜氧合指征及需要血液透析与胸管出血独立相关,而血小板计数、凝血试验、肝素剂量及血栓事件则否。
要点
- 体外膜氧合支持患儿中60%至少发生一次胸管出血,整个疗程胸管出血量中位数123 mL/kg(四分位距47-319 mL/kg)。
- 胸管出血>60 mL/kg/d的天数每增加1天,住院死亡率调整OR 1.43(95%CI 1.05-1.97,p=0.02),无PICU天数β=-4.2(95%CI -7.7至-0.6,p=0.02)。
- 胸管出血总量每增加1 mL/kg/体外膜氧合疗程,死亡率调整OR 1.002(95%CI 1.000-1.003,p=0.04)。
- 低纤维蛋白原与胸管出血独立相关,而血小板计数、凝血试验、肝素剂量及血栓事件与胸管出血无独立相关。
- 26%患儿至少1天胸管出血>100 mL/kg/d。
适用人群与场景
- 8家儿科机构中接受体外膜氧合支持的危重患儿,共514例连续患者。
研究设计与关键结果
- 研究类型:大型观察性队列研究的二次分析,纳入8家儿科机构514例连续接受体外膜氧合支持的危重患儿,无干预。
- 60%患儿至少发生一次胸管出血,整个体外膜氧合疗程胸管出血量中位数123 mL/kg(四分位距47-319 mL/kg);26%患儿至少1天胸管出血>100 mL/kg/d。
- 胸管出血>60 mL/kg/d的天数与住院死亡率升高独立相关(调整OR 1.43,95%CI 1.05-1.97,p=0.02),与无PICU天数减少独立相关(β=-4.2,95%CI -7.7至-0.6,p=0.02)。
- 胸管出血总量与死亡率升高独立相关(每mL/kg/体外膜氧合疗程,调整OR 1.002,95%CI 1.000-1.003,p=0.04)。
- 纤维蛋白原、体重、体外膜氧合指征及需要血液透析与胸管出血独立相关;血小板计数、凝血试验、肝素剂量及血栓事件与胸管出血无独立相关。
证据类型、等级与局限
- 证据类型:大型观察性队列研究的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,需进一步研究评估预防或停止胸管出血的干预措施是否影响临床结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the association between bleeding from chest tubes and clinical outcomes in children supported by extracorporeal membrane oxygenation.
DESIGN: Secondary analysis of a large observational cohort study.
SETTING: Eight pediatric institutions within the Eunice Kennedy Shriver National Institute of Child Health and Human Development's Collaborative Pediatric Critical Care Research Network.
PATIENTS: Critically ill children supported by extracorporeal membrane oxygenation.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Daily chest tube bleeding, results from hemostatic assays, transfusion volumes, 90-day PICU-free days, and mortality were collected prospectively by trained bedside extracorporeal membrane oxygenation specialists and research coordinators. Extracorporeal membrane oxygenation was employed in the care of 514 consecutive patients. Sixty percent of patients had at least one episode of chest tube bleeding (median chest tube blood volume over the entire extracorporeal membrane oxygenation course was 123 mL/kg [interquartile range, 47-319 mL/kg]). Twenty-six percent had at least 1 day of bleeding from the chest tube greater than 100 mL/kg/d. The number of days with chest tube bleeding greater than 60 mL/kg/d was independently associated with increased in-hospital mortality (adjusted odds ratio, 1.43; 95% CI, 1.05-1.97; p = 0.02) and decreased PICU-free days (beta coefficient, -4.2; 95% CI, -7.7 to -0.6; p = 0.02). The total amount of bleeding from chest tube were independently associated with increased mortality (per mL/kg/extracorporeal membrane oxygenation run; adjusted odds ratio, 1.002; 95% CI, 1.000-1.003; p = 0.04). Fibrinogen, weight, indication for extracorporeal membrane oxygenation, and need for hemodialysis were independently associated with chest tube bleeding, whereas platelet count, coagulation tests, heparin dose, and thrombotic events were not.
CONCLUSIONS: In children supported by extracorporeal membrane oxygenation, chest tube bleeding above 60 mL/kg/d was independently associated with worse clinical outcome. Low fibrinogen was independently associated with chest tube bleeding, whereas platelet count and hemostatic tests were not. Further research is needed to evaluate if interventions to prevent or stop chest tube bleeding influence the clinical outcome.
参考来源
- Nellis ME, Dalton H, Karam O, et al. Quantifiable Bleeding in Children Supported by Extracorporeal Membrane Oxygenation and Outcome. Crit Care Med. 2019. PMID: 31449061. doi:10.1097/CCM.0000000000003968
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。